| Mrs Modupe V Agueh Mccracken, MD, MPH | |
|
10755 Falls Rd, Suite 420, Lutherville, MD 21093-4515 | |
| (443) 997-0400 | |
| (410) 583-2756 |
| Full Name | Mrs Modupe V Agueh Mccracken |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 10755 Falls Rd, Lutherville, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497998819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D077211 (Maryland) | Primary |
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20050804000705 |
News Archive
Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations that can be passed from parent to child.
Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.
The end of 2019 brings with it holiday gatherings, school vacations, and the annual tradition of New Year's resolutions - with some of the most common resolutions being to exercise more and lose weight.
Juno Therapeutics, Inc. announced today that the FDA has granted Orphan Drug Designation to its JCAR015 chimeric antigen receptor product candidate. The designation was granted for treatment of acute lymphoblastic leukemia. JCAR015 Phase I trials are currently underway at Juno's collaboration partner, Memorial Sloane Kettering Cancer Center.
› Verified 3 days ago
| Entity Name | University Of Maryland St Joseph Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770836785 PECOS PAC ID: 4880846179 Enrollment ID: O20121213000234 |
News Archive
Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations that can be passed from parent to child.
Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.
The end of 2019 brings with it holiday gatherings, school vacations, and the annual tradition of New Year's resolutions - with some of the most common resolutions being to exercise more and lose weight.
Juno Therapeutics, Inc. announced today that the FDA has granted Orphan Drug Designation to its JCAR015 chimeric antigen receptor product candidate. The designation was granted for treatment of acute lymphoblastic leukemia. JCAR015 Phase I trials are currently underway at Juno's collaboration partner, Memorial Sloane Kettering Cancer Center.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Modupe V Agueh Mccracken, MD, MPH 600 N. Wolfe Street, Phipps 254, Baltimore, MD 21287 Ph: (410) 955-9045 | Mrs Modupe V Agueh Mccracken, MD, MPH 10755 Falls Rd, Suite 420, Lutherville, MD 21093-4515 Ph: (443) 997-0400 |
News Archive
Two new studies highlight the power of sequencing cancer patients' genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations that can be passed from parent to child.
Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit.
The end of 2019 brings with it holiday gatherings, school vacations, and the annual tradition of New Year's resolutions - with some of the most common resolutions being to exercise more and lose weight.
Juno Therapeutics, Inc. announced today that the FDA has granted Orphan Drug Designation to its JCAR015 chimeric antigen receptor product candidate. The designation was granted for treatment of acute lymphoblastic leukemia. JCAR015 Phase I trials are currently underway at Juno's collaboration partner, Memorial Sloane Kettering Cancer Center.
› Verified 3 days ago
Dr. Jeremy Alan King, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2330 W Joppa Rd, Suite 301, Lutherville, MD 21093 Phone: 410-583-2754 | |
Steven Lacher, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1300 York Rd Ste 190, Lutherville, MD 21093 Phone: 410-321-0882 Fax: 410-321-1161 | |
Howard Zacur, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10755 Falls Rd, Lutherville, MD 21093 Phone: 410-583-2888 | |
Edward Wallach, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10755 Falls Rd, Lutherville, MD 21093 Phone: 410-583-2888 | |
Lauren Danielle Reschke, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10751 Falls Road, Falls Concourse Building, Suite 280, Lutherville, MD 21093 Phone: 410-583-2750 | |
Dr. Richard M Ellerkmann, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1734 York Road, Lutherville Personal Physicians, Lutherville, MD 21093 Phone: 410-252-2273 | |
Dr. Sheo Pratap Sharma, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1212 York Rd Ste A101, Lutherville, MD 21093 Phone: 443-394-0520 Fax: 443-394-0524 |